Search

everythinglearnresearchcommunity

for

Search:↓

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

Two young siblings experienced hair loss without hormone issues or other skin problems.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

TNF-alpha inhibitors can cause various immune-related skin issues.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.